Related Experiment Video
Updated: Dec 3, 2025

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
Published on: November 17, 2018
Strength in Numbers: Identifying Neoantigen Targets for Cancer Immunotherapy
Rigel J Kishton1, Rachel C Lynn1, Nicholas P Restifo1
1Lyell Immunopharma, South San Francisco, CA, USA.
Abstract:
Targeting cancer neoantigens generated by tumor-exclusive somatic mutations is an attractive yet challenging strategy for the robust and specific elimination of tumor cells by cellular immunotherapy. In this issue of Cell, Wells et al. describe a consortium-based approach to optimize bioinformatics pipelines to sensitively and accurately predict immunogenic neoantigens from next-generation sequencing data.
Insights
Researchers optimized bioinformatics pipelines to accurately predict cancer neoantigens from sequencing data. This strategy aims to improve cellular immunotherapy for specific tumor cell elimination.
Area of Science:
- Oncology
- Immunology
- Bioinformatics
Background:
- Targeting cancer neoantigens from somatic mutations is a promising immunotherapy strategy.
- Accurate prediction of immunogenic neoantigens is crucial but challenging.
Purpose of the Study:
- To optimize bioinformatics pipelines for sensitive and accurate prediction of neoantigens.
- To enhance the development of cellular immunotherapies against cancer.
Main Methods:
- A consortium-based approach was used to evaluate and refine bioinformatics pipelines.
- Next-generation sequencing data was utilized for neoantigen prediction.
Main Results:
- The study successfully optimized pipelines for improved neoantigen prediction.
- Enhanced prediction accuracy facilitates the identification of immunogenic neoantigens.
Conclusions:
- Optimized bioinformatics pipelines are essential for advancing neoantigen-based cancer immunotherapy.
- This work provides a foundation for more effective cellular therapies targeting tumors.
More Related Videos
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mitogens and the Cell Cycle